3i, LP 13D and 13G filings for TransCode Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-06 4:05 pm Sale |
2024-09-30 | 13G | TransCode Therapeutics, Inc. RNAZ |
3i, LP | 0 0.000% |
-52,018 (Position Closed) |
Filing |
| 2024-07-26 4:05 pm Purchase |
2024-07-23 | 13G | TransCode Therapeutics, Inc. RNAZ |
3i, LP | 52,018 9.900% |
52,018 (New Position) |
Filing |